Becton Dickinson (BDX) Reports Q4 Fiscal 2026 Results and Provides FY 2027 Outlook
Becton, Dickinson and Company (BDX) reported strong fourth-quarter fiscal 2026 results, highlighted by $5.3 billion in revenue, representing a 5.6% increase. The company also saw significant growth in adjusted earnings per share (EPS), which rose by 27.3%. CEO Thomas Polen attributed these results to strong execution following the separation of the Life Sciences division. Looking ahead to fiscal year 2027, BDX provided an adjusted EPS outlook in the range of $13.10 to $13.30. The company expects revenue growth to remain in the low single digits for the upcoming fiscal year. This guidance reflects a period of stabilization and steady performance following recent structural changes within the organization.
Tickers: $BDX
Topics: earnings report fiscal Q4 results life sciences separation revenue growth
Read the full article at Seeking Alpha
Part of the story Mach Natural Resources Reports Q3 2026 Results and Provides 2027 Guidance (13 articles)